Omega 3 and Curcumin For Nerve Repair - Journal Article
Posted: Thu Jun 28, 2012 3:40 am
I ran across this journal article by accident. It was just published this week. I already take Omega 3 but will add Curcumin. Will give this to Dr. Howard and Dr. Hibner when I see both of them. The file is too big to upload so below is the link to the Journal of Neuroscience for downloading the whole article otherwise the abstract is below.
http://thejns.org/doi/abs/10.3171/2012.5.SPINE1216
Journal of Neurosurgery: Spine
Posted online on June 26, 2012.
Article
Dietary therapy to promote neuroprotection in chronic spinal cord injury
Laboratory investigation
Langston T. Holly, M.D.1,
Donald Blaskiewicz, M.D.1,
Aiguo Wu, Ph.D.2,
Cameron Feng, B.S.2,
Zhe Ying, B.S.2, and
Fernando Gomez-Pinilla, Ph.D.1,2
1Department of Neurosurgery, David Geffen School of Medicine at UCLA; and 2Department of Integrative Biology and Physiology, University of California, Los Angeles, California
Address correspondence to: Langston T. Holly, M.D., Department of Neurosurgery, David Geffen School of Medicine at UCLA, Center for the Health Sciences, Box 956901, Los Angeles, California 90095-6901. email: lholly@mednet.ucla.edu.
Abstract
Object
The pathogenesis of cervical spondylotic myelopathy (CSM) is related to both primary mechanical and secondary biological injury. The authors of this study explored a novel, noninvasive method of promoting neuroprotection in myelopathy by using curcumin to minimize oxidative cellular injury and the capacity of omega-3 fatty acids to support membrane structure and improve neurotransmission.
Methods
An animal model of CSM was created using a nonresorbable expandable polymer placed in the thoracic epidural space, which induced delayed myelopathy. Animals that underwent placement of the expandable polymer were exposed to either a diet rich in docosahexaenoic acid and curcumin (DHA-Cur) or a standard Western diet (WD). Twenty-seven animals underwent serial gait testing, and spinal cord molecular assessments were performed after the 6-week study period.
Results
At the conclusion of the study period, gait analysis revealed significantly worse function in the WD group than in the DHA-Cur group. Levels of brain-derived neurotrophic factor (BDNF), syntaxin-3, and 4-hydroxynonenal (4-HNE) were measured in the thoracic region affected by compression and lumbar enlargement. Results showed that BDNF levels in the DHA-Cur group were not significantly different from those in the intact animals but were significantly greater than in the WD group. Significantly higher lumbar enlargement syntaxin-3 in the DHA-Cur animals combined with a reduction in lipid peroxidation (4-HNE) indicated a possible healing effect on the plasma membrane.
Conclusions
Data in this study demonstrated that DHA-Cur can promote spinal cord neuroprotection and neutralize the clinical and biochemical effects of myelopathy.
http://thejns.org/doi/abs/10.3171/2012.5.SPINE1216
Journal of Neurosurgery: Spine
Posted online on June 26, 2012.
Article
Dietary therapy to promote neuroprotection in chronic spinal cord injury
Laboratory investigation
Langston T. Holly, M.D.1,
Donald Blaskiewicz, M.D.1,
Aiguo Wu, Ph.D.2,
Cameron Feng, B.S.2,
Zhe Ying, B.S.2, and
Fernando Gomez-Pinilla, Ph.D.1,2
1Department of Neurosurgery, David Geffen School of Medicine at UCLA; and 2Department of Integrative Biology and Physiology, University of California, Los Angeles, California
Address correspondence to: Langston T. Holly, M.D., Department of Neurosurgery, David Geffen School of Medicine at UCLA, Center for the Health Sciences, Box 956901, Los Angeles, California 90095-6901. email: lholly@mednet.ucla.edu.
Abstract
Object
The pathogenesis of cervical spondylotic myelopathy (CSM) is related to both primary mechanical and secondary biological injury. The authors of this study explored a novel, noninvasive method of promoting neuroprotection in myelopathy by using curcumin to minimize oxidative cellular injury and the capacity of omega-3 fatty acids to support membrane structure and improve neurotransmission.
Methods
An animal model of CSM was created using a nonresorbable expandable polymer placed in the thoracic epidural space, which induced delayed myelopathy. Animals that underwent placement of the expandable polymer were exposed to either a diet rich in docosahexaenoic acid and curcumin (DHA-Cur) or a standard Western diet (WD). Twenty-seven animals underwent serial gait testing, and spinal cord molecular assessments were performed after the 6-week study period.
Results
At the conclusion of the study period, gait analysis revealed significantly worse function in the WD group than in the DHA-Cur group. Levels of brain-derived neurotrophic factor (BDNF), syntaxin-3, and 4-hydroxynonenal (4-HNE) were measured in the thoracic region affected by compression and lumbar enlargement. Results showed that BDNF levels in the DHA-Cur group were not significantly different from those in the intact animals but were significantly greater than in the WD group. Significantly higher lumbar enlargement syntaxin-3 in the DHA-Cur animals combined with a reduction in lipid peroxidation (4-HNE) indicated a possible healing effect on the plasma membrane.
Conclusions
Data in this study demonstrated that DHA-Cur can promote spinal cord neuroprotection and neutralize the clinical and biochemical effects of myelopathy.